Comprehensive, GOLD-guideline-based care for chronic obstructive pulmonary disease, emphysema, and chronic bronchitis — preserving your lung function and improving quality of life.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition characterised by persistent airflow limitation that is not fully reversible. It encompasses emphysema (destruction of the air sacs) and chronic bronchitis (inflammation and narrowing of the bronchial tubes).
COPD is the third leading cause of death worldwide. In Australia, it affects approximately 1 in 13 people over the age of 40. Smoking is the primary cause, accounting for up to 85% of cases, though long-term exposure to occupational dusts, chemicals, and air pollution also contributes significantly.
"Early diagnosis and specialist-guided management can significantly slow COPD progression, reduce hospitalisation rates, and restore meaningful physical capacity — even for patients with advanced disease."
Our pulmonologists use the GOLD (Global Initiative for Chronic Obstructive Lung Disease) framework to stage your disease precisely and tailor your treatment to your specific exacerbation history, symptoms, and lung function results.
COPD symptoms often develop slowly and are frequently dismissed as "getting older." Early detection leads to dramatically better outcomes.
Persistent shortness of breath, especially during physical activity
Chronic cough, often worse in the morning
Regular production of sputum (phlegm) from the airways
Wheezing or noisy breathing at rest or with minimal effort
Fatigue and reduced exercise tolerance that worsens over time
Unintentional weight loss in moderate-to-severe disease
Barrel chest (hyperinflation) in advanced emphysema
Frequent chest infections that are slow to resolve
From initial spirometry to long-term disease management, our team provides continuity of care at every stage of your condition.
Post-bronchodilator spirometry to confirm airflow obstruction, combined with symptom scoring (mMRC, CAT) to determine your GOLD stage and exacerbation risk.
High-resolution CT chest to evaluate emphysema distribution, hyperinflation, and bronchiectasis. Arterial blood gas testing and 6-minute walk test for functional capacity.
Stepped inhaler therapy with LAMA, LABA, and ICS/LABA combinations as appropriate, plus smoking cessation support, vaccination planning, and exacerbation prevention strategies.
Referral to our supervised pulmonary rehabilitation program, home oxygen assessment, advance care planning discussions, and regular specialist review.
There is no cure for COPD, but our specialist-led treatment programme can slow progression, improve your breathing, and help you stay active and independent for longer.
Start Your AssessmentLAMA (e.g. tiotropium, umeclidinium) and LABA (e.g. salmeterol, indacaterol) inhalers — individually or as triple therapy — to open the airways and reduce breathlessness.
A supervised 8-week exercise and education programme proven to reduce hospitalisation, improve exercise tolerance, and enhance quality of life for COPD patients.
For patients with chronic hypoxaemia (low blood oxygen), home oxygen therapy prescribed after formal arterial blood gas assessment to protect the heart and brain.
A minimally invasive bronchoscopic procedure to reduce hyperinflation in selected emphysema patients — significantly improving breathlessness and exercise capacity.
Structured cessation programmes including pharmacotherapy (varenicline, NRT) and behavioural counselling — the single most effective intervention to slow COPD progression.
COPD cannot be cured or reversed, but it can be effectively managed to slow progression, relieve symptoms, and prevent exacerbations. Stopping smoking at any stage is the most impactful step you can take.
Emphysema is one component of COPD. It refers specifically to the destruction of the alveolar walls (air sacs), resulting in large air spaces and reduced gas exchange. Most COPD patients have a combination of emphysema and chronic bronchitis.
An exacerbation is an acute worsening of COPD symptoms — usually triggered by respiratory infection or air pollution. Prevention involves staying up-to-date with vaccinations, using inhalers correctly, avoiding triggers, and having a written action plan for early self-management.
Yes — pulmonary rehabilitation is one of the most evidence-based treatments for COPD. Studies consistently show it reduces breathlessness, improves exercise capacity, decreases hospital admissions, and significantly improves quality of life, even in severe disease.
Endobronchial valve therapy is suitable for selected patients with severe emphysema and significant hyperinflation who meet specific CT and functional criteria. Your pulmonologist will assess your eligibility with a combination of CT analysis, lung function testing, and bronchoscopic evaluation.
Early specialist intervention makes a measurable difference. Book a consultation and start your personalised management plan today.